bw a1433u has been researched along with cv 1808 in 1 studies
Studies (bw a1433u) | Trials (bw a1433u) | Recent Studies (post-2010) (bw a1433u) | Studies (cv 1808) | Trials (cv 1808) | Recent Studies (post-2010) (cv 1808) |
---|---|---|---|---|---|
26 | 0 | 0 | 64 | 0 | 13 |
Protein | Taxonomy | bw a1433u (IC50) | cv 1808 (IC50) |
---|---|---|---|
Adenosine receptor A1 | Rattus norvegicus (Norway rat) | 1.38 | |
Adenosine receptor A2b | Rattus norvegicus (Norway rat) | 0.145 | |
Adenosine receptor A2a | Rattus norvegicus (Norway rat) | 0.145 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cahill, BE; Haile, DM; Kadowitz, PJ; Neely, CF | 1 |
1 other study(ies) available for bw a1433u and cv 1808
Article | Year |
---|---|
Adenosine and ATP produce vasoconstriction in the feline pulmonary vascular bed by different mechanisms.
Topics: Adenosine; Adenosine Diphosphate; Adenosine Triphosphate; Animals; Bridged Bicyclo Compounds, Heterocyclic; Cats; Cyclooxygenase Inhibitors; Fatty Acids, Unsaturated; Hydrazines; Lung; Meclofenamic Acid; Phenylisopropyladenosine; Purinergic Antagonists; Receptors, Prostaglandin; Receptors, Purinergic; Receptors, Thromboxane; Thromboxane A2; Vasoconstriction; Vasodilator Agents; Xanthines | 1991 |